Past Event - 3 April 09
CNETS organised a free seminar, its second public event, held in Singapore
at the National Cancer Centre Theatre on 3 April 2009.
"The Evolution of Diagnostic and Treatment Options for Carcinoid and Neuroendocrine Patients"
Presented by Professor Dr. Larry K. Kvols
In his
landmark article for the first issue of
the Journal of Clinical Oncology in 1983, Dr. C.G. Moertel concluded:
"The patient with carcinoid tumor should not be a fascinating curio for grand rounds exhibition.
He should be a focal point for research involving an experienced, multidisciplinary clinical team supported
by devoted basic scientists. If our patient resources and efforts can be concentrated in this manner, the
carcinoid should be a strong candidate for the next medically curable cancer."
Dr. Kvols is an expert in carcinoid disease who worked with Dr.
Moertel for many years at the Mayo Clinic, and recently authored a
retrospective article examining Moertel's remarkable
insights for the 25th anniversary issue of JCO. In his talk to our audience in Singapore,
Dr. Kvols shared with us how the diagnosis and treatment of neuroendocrine tumors has evolved
in the past 25 years.
Larry K. Kvols is a Professor of Interdisciplinary Oncology and Head of the Neuroendocrinology Section at
the Moffitt Cancer Center in Tampa Florida. Prior to joining Moffitt, Dr. Kvols was CEO and Director of
the University of New Mexico Cancer Research and Treatment Center. He is a graduate of Baylor College of
Medicine, completing his residency, internship and fellowship at Johns Hopkins Hospital. He was Professor
of Oncology at the Mayo Medical School and the Mayo Clinic. His research interests are focused on the
diagnosis and treatment of neuroendocrine tumors, for which he is world-renowned.
The talk was introduced by William Claxton, co-founder of CNETS Singapore, and Dr. Liau Kui Hin, Consultant
Surgeon and Chief of Hepatobiliary and Pancreatic Surgery at Tan Tock Seng Hospital, Singapore.
|
|
|
Webcast
As part of our outreach to patients, caregivers and physicians throughout the region,
we are webcasting the presentation by Dr. Kvols. Actually, this webcast was transmitted
live over the Internet, and announced via the ACOR forum.
This was the first live transmission of a seminar on
carcinoid and neuroendocrine tumors, and to achieve it we used a new software tool known as
'Wirecast' which allows us to switch between video and slides while transmitting and recording
the webcast. We also used a software known as 'Cursor Attention' to make the cursor easily
visible both to attendees in the room and viewers on the Internet.
Unfortunately, there was a technical issue that required us to switch machines just prior to the
transmission. The backup PC we used was underpowered and dropped frames resulting in choppy audio.
Also, during the first 2 minutes of the video the audio levels were too low. We hope you will
excuse these technical faults, and enjoy the webcast nonetheless.
|
|
|
|
|
|
|
|
|
|
|
|
Supporting organisations
This event was supported by National Cancer Center of Singapore, the Chapter of Gastroenterologists
College of Physicians, and Novartis Oncology.
|
|
|
|
